Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bavarian Nordic A S (OP:BVNKF)

27.80 UNCHANGED
Last Price Updated: 9:30 AM EDT, Jun 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 27.80
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 27.80
Today's Range 27.80 - 27.80
52wk Range 26.77 - 37.60
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat ↗
The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, while partnering with WHO and UNICEF. 
Via Benzinga
News headline image
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows ↗
Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperform Bavarian Nordic's Jynneos in reducing severe disease in monkeys. 
Via Benzinga

Performance

YTD
-8.9%
-8.9%
1 Month
-0.1%
-0.1%
3 Month
-9.4%
-9.4%
6 Month
-7.3%
-7.3%
1 Year
+3.8%
+3.8%

More News

Read More
News headline image
Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic ↗
Via Benzinga
News headline image
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain ↗
Via Benzinga
News headline image
Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency ↗
Via Benzinga
News headline image
Bavarian Nordic Recruits US Firm For Packaging Services For Its Monkeypox Vaccine ↗
Via Benzinga
News headline image
Bavarian Nordic's Monkeypox Vaccine Gets Thumbs Up From EU Regulator ↗
Via Benzinga
News headline image
Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines ↗
Via Benzinga
News headline image
West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies ↗
Via Benzinga
News headline image
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa ↗
Via Benzinga
News headline image
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox ↗
Via Benzinga
News headline image
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed ↗
Via Benzinga
News headline image
SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report ↗
Via Benzinga
News headline image
Bavarian Nordic Making All Efforts To Stretch Capacity To Boost Monkeypox Vaccine Supplies ↗
Via Benzinga
News headline image
Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch ↗
Via Benzinga
News headline image
Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test ↗
Via Benzinga
News headline image
Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment ↗
Via Benzinga
News headline image
WeTrade Shares Soar On Collaboration Over Exclusive COVID-19 Omicron Disinfectant ↗
Via Benzinga
News headline image
A Biopharma Working On Malaria, Norovirus Vaccines Threw It's Hat In The Monkeypox Ring ↗
Via Benzinga
News headline image
Benzinga Before The Bell: More Amazon Workers Join Union Over Pay and Work Conditions, UK Inflation Highest In 40 Years, Sole Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand And Other Top Financial Stories Wednesday, August 17 ↗
Via Benzinga
News headline image
The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand ↗
Via Benzinga
News headline image
Bavarian Nordic's Monkeypox Vaccine Scores EU Approval As WHO Declares Global Health Emergency ↗
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings ↗
Via Benzinga
News headline image
Bavarian Nordic Inks Multiple Supply Pact For Its Monkey pox Vaccine, Updates FY22 Guidance ↗
Via Benzinga
News headline image
Bavarian Nordic Launches COVID-19 Booster Study To Compare Against Pfizer/BioNTech Shot ↗
Via Benzinga

Frequently Asked Questions

Is Bavarian Nordic A S publicly traded?
Yes, Bavarian Nordic A S is publicly traded.
What exchange does Bavarian Nordic A S trade on?
Bavarian Nordic A S trades on the OTC Traded
What is the ticker symbol for Bavarian Nordic A S?
The ticker symbol for Bavarian Nordic A S is BVNKF on the OTC Traded
What is the current price of Bavarian Nordic A S?
The current price of Bavarian Nordic A S is 27.80
When was Bavarian Nordic A S last traded?
The last trade of Bavarian Nordic A S was at 06/17/26 09:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.